Manulife (Manufacturers Life Insurance)
JNCE

Manulife (Manufacturers Life Insurance)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,379
Closed -$104K – 3217
2022
Q1 		$104K Sell
15,379
-3,870
-20% -$27.6K ﹤0.01% 2954
2021
Q4 		$161 Sell
19,249
-535
-3% -$4.41K ﹤0.01% 2968
2021
Q3 		$147K Buy
+19,784
New +$123K ﹤0.01% 3069
2021
Q2 		– Sell
-11,555
Closed -$119K – 3320
2021
Q1 		$119K Buy
+11,555
New +$127K ﹤0.01% 3026
2020
Q4 		– Sell
-11,765
Closed -$96K – 3043
2020
Q3 		$96K Hold
11,765
– – ﹤0.01% 2804
2020
Q2 		$86K Buy
11,765
+148
+1% +$798 ﹤0.01% 2795
2020
Q1 		$55K Buy
+11,617
New +$66.9K ﹤0.01% 2726
2018
Q3 		– Sell
-1,005
Closed -$8K – 4009
2018
Q2 		$8K Sell
1,005
-10,824
-92% -$156K ﹤0.01% 3972
2018
Q1 		$264K Sell
11,829
-825
-7% -$18.3K ﹤0.01% 2806
2017
Q4 		$161K Buy
12,654
+503
+4% +$7.39K ﹤0.01% 3174
2017
Q3 		$189K Buy
12,151
+12,032
+10,111% +$170K ﹤0.01% 3027
2017
Q2 		$2K Buy
+119
New +$2.55K ﹤0.01% 4153

Other funds holding JNCE

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s JNCE Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2022, closing a stake of 15,379 shares — an estimated $104K sold.

Manulife (Manufacturers Life Insurance) first reported a position in JNCE in Q2 2017 and held it in 12 quarters. The position peaked at $264K in Q1 2018. 102 funds tracked by Wall St. Rank hold JNCE as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 15,379 Jounce Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $104K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Jounce Therapeutics, Inc. Common Stock in Q2 2017 and held it in 12 quarters.
  • Manulife (Manufacturers Life Insurance)'s Jounce Therapeutics, Inc. Common Stock position peaked at $264K in Q1 2018.
  • 102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.